Insider Transactions in Q2 2025 at Madrigal Pharmaceuticals, Inc. (MDGL)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 20
2025
|
Kenneth Bate Director |
BUY
Grant, award, or other acquisition
|
Direct |
715
+21.39%
|
-
|
|
Jun 20
2025
|
Richard S Levy Director |
BUY
Grant, award, or other acquisition
|
Direct |
715
+3.26%
|
-
|
|
Jun 20
2025
|
Baker Bros. Advisors LP |
BUY
Grant, award, or other acquisition
|
Indirect |
2,860
+0.42%
|
-
|
|
Jun 20
2025
|
Jacqualyn A Fouse Director |
BUY
Grant, award, or other acquisition
|
Direct |
203
+15.62%
|
-
|
|
Jun 20
2025
|
Paul A Friedman Director |
BUY
Grant, award, or other acquisition
|
Direct |
715
+0.38%
|
-
|
|
Jun 20
2025
|
James M Daly Director |
BUY
Grant, award, or other acquisition
|
Direct |
715
+21.39%
|
-
|
|
May 15
2025
|
David Soergel Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,545
+50.0%
|
-
|
|
Apr 10
2025
|
Richard S Levy Director |
BUY
Exercise of conversion of derivative security
|
Direct |
9,470
+31.62%
|
$615,550
$65.06 P/Share
|